what defines the carcinogenic potency of nitrosamine?
Published 1 year ago • 971 plays • Length 14:01Download video MP4
Download video MP3
Similar videos
-
9:13
how to predict the potency category of nitrosamine as per new ema updates
-
26:42
how to use cpca to define ai limit of nitrosamine?
-
9:27
cpca - a new approach to define nitrosamine ai limit
-
10:21
is the less than lifetime (ltl) limit applies to nitrosamines?
-
11:47
how to derive an ai for new n-nitrosamine?
-
12:37
which limits apply for nitrosamines in medicinal products?
-
9:37
loq requirement for nitrosamine impurity test procedure
-
14:58
why are a few “α hydrogen scores” not given in fda’s & ema’s nitrosamine guidelines?
-
6:29
why the ai for ndma is 96ng/day?
-
9:35
how to choose nitrosamine standard and sample concentration
-
0:12
vitamins for brain health 🧠 | jim kwik
-
37:46
unlocking health: an introduction to nutrigenomics
-
12:39
are all c18 columns the same?
-
0:46
endocannabinoids! uncovering the secret pharmacy in your brain!
-
0:53
food is medicine | grro
-
1:58
the brave new world of biopharmaceutical manufacturing: speed, capacity, and quality
-
2:22
the role of nutrigenomics in healthy metabolism and lifestyle
-
26:58
genetics of grocery shopping
-
11:58
manufacturing of nanomedicines – a gmp perspective